Innovent Announces NMPA Acceptance of a Supplemental New Drug Application for Sintilimab in Combination with Chemotherapy as First-Line Treatment for Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
SAN FRANCISCO and SUZHOU, China, Nov. 4, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, today announced that the National Medical Products Administration (NMPA) of China has accepted the supplemental New Drug Application (sNDA) for sintilimab...
Invitation to the presentation of Elekta’s second quarter 2021/22
STOCKHOLM, Nov. 4, 2021 /PRNewswire/ --Elekta (EKTA-B.ST) invites analysts and investors to a presentation of the second quarter 2021/22 at 10:00 a.m. CET on November 25. The interim report for the second quarter will be published at 7:30 a.m. CET on the same day. The company's development will be presented by Elekta's President and CEO, Gustaf Salford, together with...
New progress of studies on Lianhua Qingwen’s mechanism to fight against SARS-CoV-2
BEIJING, Nov. 4, 2021 /PRNewswire/ -- During the efforts to prevent and control the epidemic, "3 medicines and 3 prescriptions" are selected from traditional Chinese medicine in China, including the representative medicine "Lianhua Qingwen", produced by Yiling pharmaceutical, which has been widely used during public epidemic prevention. In addition, with the increasing popularity of the drug, scientists have carried...
Envirotainer Opens New station in Guangzhou, China
STOCKHOLM, Nov. 4, 2021 /PRNewswire/ -- Envirotainer, the global market leader in secure cold chain solutions for air transportation of pharmaceuticals, today announced that they are opening a new station in Guangzhou, China to provide ground handling of container types RKN e1 and RAP e2. Envirotainer, the global market leader in secure cold chain solutions for air transportation of...
Dymax Releases First-of-Kind Adhesives for Medical Wearables Assembly
SINGAPORE, Nov. 4, 2021 /PRNewswire/ -- Dymax, leading global manufacturer of rapid-curing materials and equipment, introduces the 2000-MW series of light-curable adhesives specifically developed to address customer requirements and market trends within the rapidly evolving medical device wearables market. Dymax 2000-MW Series Adhesives for Medical Wearables Assembly This new range of structural medical adhesives are the...
Medtecs to showcase PPE and technologies from Taiwan at MEDICA 2021
TAIPEI, Nov. 4, 2021 /PRNewswire/ -- It is now half-way through autumn and the COVID-19 pandemic still persists. The global death toll has reached over 5 million yet only 45.4% of the global population has received at least one dose of vaccine. To make matters worse, a new subvariant of the virus codenamed AY.4.2 is growing in number in...
Smile Cosmetics Brand, Zenyum, Launches in its 9th Market to Empower Confident Smiles in Japan
SINGAPORE, Nov. 4, 2021 /PRNewswire/ -- Singapore-based 'Smile Cosmetics' company Zenyum announced its launch in Japan today, expanding its reach across Asia in its 9th market to date. The successful start-up was named a LinkedIn Top Startup in 2021, and is currently one of Asia's fastest growing consumer dental products brands with presence in Singapore, Hong Kong, Malaysia, Taiwan,...
Sensational artemisinin-piperaquine for treatment of COVID-19 in prospect
GUANGZHOU, China, Nov. 3, 2021 /PRNewswire/ -- Artequick artemisinin and piperaquine tablets have once again become buzzwords across the globe, as most recently, their effectiveness in treating COVID-19 was hotly debated by live streamers on overseas social media and we media platforms. These drugs first came to the industry's attention after the International Journal of Antimicrobial Agents published a...
Novavax Files COVID-19 Vaccine for Provisional Approval in New Zealand
- Submission to New Zealand's Medsafe marks the first protein-based COVID-19 vaccine submitted for authorization to regulatory authorities in New Zealand - All modules required for regulatory review of Novavax vaccine, including CMC data, are now complete for Medsafe GAITHERSBURG, Md., Nov. 3, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology...
Gold Technology for Immune Response Cancer Therapy Licensed to OncoTEX
AUSTIN, Texas, Nov. 3, 2021 /PRNewswire/ -- OncoTEX Inc. (OncoTEX), a US oncology company and member of The iQ Group Global portfolio, is pleased to announce it has acquired a gold compound platform technology that induces the body's immune system to destroy cancer cells. The technology has been developed by the University of Texas at Austin, Georgia Southern...
